These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33774082)

  • 1. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
    Clarke CL; Prendecki M; Dhutia A; Gan J; Edwards C; Prout V; Lightstone L; Parker E; Marchesin F; Griffith M; Charif R; Pickard G; Cox A; McClure M; Tedder R; Randell P; Greathead L; Guckian M; McAdoo SP; Kelleher P; Willicombe M
    Kidney Int; 2021 Jun; 99(6):1470-1477. PubMed ID: 33774082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.
    Cohen DE; Sibbel S; Marlowe G; Bludorn K; Miller D; Kelley T; Connaire J; Young A; Tentori F; Brunelli SM
    J Am Soc Nephrol; 2021 Aug; 32(8):1880-1886. PubMed ID: 34215666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
    Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
    JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
    Sakhi H; Dahmane D; Attias P; Kofman T; Bouvier M; Lapidus N; Fourati S; El Karoui K;
    J Am Soc Nephrol; 2021 May; 32(5):1033-1036. PubMed ID: 33637518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
    Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
    Front Immunol; 2021; 12():793953. PubMed ID: 34899762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses.
    Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA;
    Cell Rep; 2022 Feb; 38(6):110345. PubMed ID: 35090598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom.
    Wickens O; Chinnadurai R; Mannan F; Svendsen F; Baig MY; Chukwu C; Ali I; Summersgill C; Evans D; Antoine BV; Oxton J; Mairs N; Flanagan E; Oliver R; Kalra PA; Poulikakos D
    BMC Nephrol; 2021 Apr; 22(1):154. PubMed ID: 33902482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
    Batra G; Murugesan DR; Raghavan S; Chattopadhyay S; Mehdi F; Ayushi ; Gosain M; Singh S; Das SJ; Deshpande S; Sonar S; Jakhar K; Bhattacharya J; Mani S; Pandey AK; Sankalp ; Goswami S; Das A; Dwivedi T; Sharma N; Kumar S; Sharma P; Kapoor S; Kshetrapa P; Wadhwa N; Thiruvengadam R; Kumar R; Gupta R; Garg PK; Bhatnagar S
    Indian J Med Res; 2023 Jun; 157(6):509-518. PubMed ID: 37322634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies.
    Jarlhelt I; Pérez-Alós L; Bayarri-Olmos R; Hansen CB; Petersen MS; Weihe P; Armenteros JJA; Madsen JR; Nielsen JPS; Hilsted LM; Iversen KK; Bundgaard H; Nielsen SD; Garred P
    Microbiol Spectr; 2023 Sep; 11(5):e0179623. PubMed ID: 37738355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection.
    El-Khoury JM; Schulz WL; Durant TJS
    J Appl Lab Med; 2021 Jul; 6(4):1005-1011. PubMed ID: 33822964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
    Lumley SF; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Jeffery K; Eyre DW;
    N Engl J Med; 2021 Feb; 384(6):533-540. PubMed ID: 33369366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.
    Anand S; Montez-Rath ME; Han J; Garcia P; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Chertow GM; Parsonnet J
    Ann Intern Med; 2021 Aug; 174(8):1073-1080. PubMed ID: 34000201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
    Clarke C; Prendecki M; Dhutia A; Ali MA; Sajjad H; Shivakumar O; Lightstone L; Kelleher P; Pickering MC; Thomas D; Charif R; Griffith M; McAdoo SP; Willicombe M
    J Am Soc Nephrol; 2020 Sep; 31(9):1969-1975. PubMed ID: 32732391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
    Goupil R; Benlarbi M; Beaubien-Souligny W; Nadeau-Fredette AC; Chatterjee D; Goyette G; Gunaratnam L; Lamarche C; Tom A; Finzi A; Suri RS;
    CMAJ; 2021 May; 193(22):E793-E800. PubMed ID: 33980499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
    Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses.
    Harris BHL; Zuhair M; Di Giovannantonio M; Rosadas C; Khan M; Short CE; Thaventhiran T; Quinlan R; Taylor A; Calvez R; Taylor GP; Tedder RS; McClure MO; Fertleman M
    J Infect Dis; 2021 Feb; 223(2):192-196. PubMed ID: 33535238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.